Rhythm Pharmaceuticals Inc’s recent filing unveils that its Corporate Controller & CAO German Christopher Paul unloaded Company’s shares for reported $18655.0 on Mar 21 ’25. In the deal valued at $54.23 per share,344 shares were sold. As a result of this transaction, German Christopher Paul now holds 2,889 shares worth roughly $0.16 million.
Then, Mazabraud Yann sold 75,000 shares, generating $3,861,272 in total proceeds. Upon selling the shares at $51.48, the EVP, Head of International now owns 40,370 shares.
Before that, YANN MAZZABRAUD bought 75,000 shares. Rhythm Pharmaceuticals Inc shares valued at $3,768,000 were divested by the Officer at a price of $50.24 per share.
BofA Securities upgraded its Rhythm Pharmaceuticals Inc [RYTM] rating to a Buy from a a Neutral in a research note published recently. Jefferies began covering RYTM with “Buy” recommendation on January 02, 2025. Oppenheimer started covering the stock on December 20, 2024. It rated RYTM as “an Outperform”.
Price Performance Review of RYTM
On Monday, Rhythm Pharmaceuticals Inc [NASDAQ:RYTM] saw its stock jump 17.06% to $54.96. Over the last five days, the stock has gained 3.76%. Rhythm Pharmaceuticals Inc shares have fallen nearly -1.82% since the year began. Nevertheless, the stocks have risen 37.06% over the past one year. While a 52-week high of $68.58 was reached on 02/05/25, a 52-week low of $35.17 was recorded on 04/07/25. SMA at 50 days reached $54.54, while 200 days put it at $52.37.
Levels Of Support And Resistance For RYTM Stock
The 24-hour chart illustrates a support level at 48.61, which if violated will result in even more drops to 42.25. On the upside, there is a resistance level at 58.61. A further resistance level may holdings at 62.25. The Relative Strength Index (RSI) on the 14-day chart is 54.19, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.09, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 9.40%. Stochastics %K at 39.72% indicates the stock is a holding.
How much short interest is there in Rhythm Pharmaceuticals Inc?
A steep rise in short interest was recorded in Rhythm Pharmaceuticals Inc stocks on 2025-03-14, dropping by -0.7 million shares to a total of 4.71 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 5.41 million shares. There was a decline of -14.87%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on October 21, 2024 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $70 price target.
